E. Molina-holgado et al., LPS/IFN-gamma cytotoxicity in oligodendroglial cells: role of nitric oxideand protection by the anti-inflammatory cytokine IL-10, EUR J NEURO, 13(3), 2001, pp. 493-502
Proinflammatory mediators have been implicated in demyelinating disorders,
including multiple sclerosis, whereas it has been proposed that the anti-in
flammatory cytokines interleukin- (IL-) 4 and IL-10 participate in disease
recovery. The present study analysed the effect of interferon-gamma (IFN-ga
mma) and bacterial endotoxin (lipopolysaccharide, LPS) on proliferation and
survival of progenitors and differentiated oligodendrocytes. We also inves
tigated the presence of receptors for IL-4 and IL-10 in oligodendroglial ce
lls and explored a possible protective action of IL-4 and IL-10 in cultures
following LPS/IFN-gamma. Finally, the role of endogenous nitric oxide (NO)
on cell viability and the modulatory action of IL-4 and IL-10 on inducible
nitric oxide synthase (iNOS) expression were also analysed. We report that
LPS and/or IFN-gamma reduced proliferation and viability of oligodendrogli
al cells. Cell death, presumably by apoptosis as evidence by TUNEL and Anne
xin V binding, was observed following LPS/IFN-gamma, progenitors being more
sensitive than differentiated cells. At both developmental stages, LPS/IFN
-gamma -treated cultures expressed iNOS protein and released micromolar con
centrations of NO. In progenitors, LPS/IFN-gamma -mediated cell damage was
partially dependent on endogenous NO production, whereas NO was fundamental
for cytotoxicity of differentiated oligodendrocytes. Both cell types expre
ssed mRNA for IL-4 and IL-10 receptors and expression of IL-10 receptors at
the protein level was also demonstrated. Treatment with either cytokine in
hibited the expression of iNOS resulting from the proinflammatory stimulati
on. IL-10 was more effective than IL-4 in suppressing iNOS expression and,
interestingly, IL-10 conferred protection against oligodendroglial death ev
oked by LPS/IFN-gamma. Our data raise the question of whether IL-10 may pla
y a protective role in demyelinating diseases, not only downregulating the
function of inflammatory cells but also promoting survival of progenitors a
nd differentiated oligodendrocytes.